Skip to content

Clinical trials

Observational Scleroderma, Diffuse trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Diffuse Phase: Observational Clear all

69 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20041
20051
20063
20071
20103
20111
20124
20137
20143
20153
20163
20171
20184
20191
20202
20214
20225
20234
20247
20255
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31
Recruiting16
Unknown status9
Not yet recruiting5
Terminated3
Withdrawn3
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Duke University5
Hacettepe University3
Assiut University2
Elpen Pharmaceutical Co. Inc.2
Johns Hopkins University2
Louisiana State University Health Sciences Center in New Orleans2
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)2
Sanguine Biosciences2
University Hospital, Toulouse2
University of Manchester2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Diffuse69
Scleroderma, Systemic21
Arthritis, Rheumatoid12
Sjogren's Syndrome11
Lupus Erythematosus, Systemic10
Autoimmune Diseases9
Arthritis, Psoriatic7
Dermatomyositis6
Hypertension, Pulmonary6
Myositis6

Trials

Showing 26 to 50 of 69. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.